Stanhope, Mitsui Fudosan and AIMCo have announced that Autolus Limited (Autolus) has signed on to become the first major life sciences company to take space at White City Place. Autolus’ new location signals the entry of White City Place into the emerging hub of innovative life sciences start-ups and other technology companies anchored by Imperial College’s White City campus, and underpinned by the London Borough of Hammersmith and Fulham’s Industrial Strategy.
Autolus will initially be taking the fifth floor of the MediaWorks building with approximately 33,000 square feet of office and lab space and is due to occupy the building in October 2018. Autolus is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer.
David Camp, Chief Executive, Stanhope said, “Autolus is an exciting and innovative life sciences company and we are delighted that they will be remaining in White City, where they were first established, and bringing life sciences to White City Place. We are talking to a number of other interesting occupiers both for White City Place and for the new extension to the British Library and the new Alan Turing Institute, as part of the transformation of London’s Knowledge Quarter.”